Clinical diagnosis of pheochromocytoma and paraganglioma‐induced secondary hypertension through UPLC‐MS/MS analysis of plasma catecholamines and their metabolites
The Journal of Clinical Hypertension · 2024
DOI: 10.1111/jch.14779 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Hypertension, 2024. Verfasst von Weiyun Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, China. Hauptthemen laut MEDLINE: Pheochromocytoma, Hypertension, Paraganglioma, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Program of Guangzhou, China, Guangdong Medical Science and Technology Research Fund.
Abstract (Originalsprache)
This study aimed to elucidate the clinical diagnostic value of plasma catecholamines and their metabolites for pheochromocytoma and paraganglioma (PPGL)‐induced secondary hypertension using ultraperformance liquid chromatography‐mass spectrometry (UPLC‐MS/MS). The study population included 155 patients with PPGL that were divided into the PPGL with hypertension ( n = 79) and a PPGL without hypertension ( n = 76) groups, and 90 healthy volunteers and 90 patients with primary hypertension as the control groups. UPLC‐MS/MS was performed to detect plasma levels of catecholamines and their metabolites, including dopamine, vanillylmandelic acid (VMA), norepinephrine, metanephrine, and normetanephrine. Receiver operating characteristic curves were generated to analyze the diagnostic value of the plasma levels of catecholamines and their metabolites in PPGL‐induced secondary hypertension. Patients in the primary hypertension and PPGL without hypertension groups had higher levels of dopamine, VMA, norepinephrine, metanephrine, and normetanephrine than patients in the normal group (all p < .05). On the other hand, patients in the PPGL with hypertension group had higher levels of dopamine, VMA, norepinephrine, metanephrine, and normetanephrine than patients in the normal, primary hypertension, and PPGL without hypertension groups (all p < .05). Collectively, our findings showed that dopamine, VMA, norepinephrine, metanephrine, and normetanephrine are all effective biomarkers for the diagnosis of PPGL and PPGL‐induced secondary hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, China.
- The First School of Clinical Medicine, Southern Medical University, Guangzhou, China.
ORCID-Profile: Zhaohui Sun
Förderung
- Science and Technology Program of Guangzhou, China
- Guangdong Medical Science and Technology Research Fund
Zitieren
APA
Zhang, W., Li, X., Li, W., Zhang, Y., Cai, J., Feng, S., & Sun, Z. (2024). Clinical diagnosis of pheochromocytoma and paraganglioma‐induced secondary hypertension through UPLC‐MS/MS analysis of plasma catecholamines and their metabolites. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.14779
Vancouver
Zhang W, Li X, Li W, Zhang Y, Cai J, Feng S, et al. Clinical diagnosis of pheochromocytoma and paraganglioma‐induced secondary hypertension through UPLC‐MS/MS analysis of plasma catecholamines and their metabolites. The Journal of Clinical Hypertension. 2024. doi:10.1111/jch.14779
BibTeX
@article{Zhang2024,
author = {Zhang, Weiyun and Li, Xiao and Li, Wanqin and Zhang, Yanmei and Cai, Jiajia and Feng, Shiyu and Sun, Zhaohui},
title = {Clinical diagnosis of pheochromocytoma and paraganglioma‐induced secondary hypertension through UPLC‐MS/MS analysis of plasma catecholamines and their metabolites},
journal = {The Journal of Clinical Hypertension},
year = {2024},
doi = {10.1111/jch.14779}
}
EUVIMED